Buy or sell HyperScience stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

HyperScience Stock

Document automation software

Founded

2014

Notable Investors

TD Ameritrade

Headquarters

New York NY, US

Total Funding

$48.9M

About HyperScience Stock

HyperScience's proprietary machine learning solution extracts and transcribes handwritten, cursive script, and machine printed text with up to 95% automation and over 99.5% accuracy, helping enterprises reduce costs, streamline operations, and drive new business and revenue opportunities. HyperScience is working with some of the world’s largest companies, including TD Ameritrade and QBE, and is backed by leading investors. For more information visit www.hyperscience.com.

Investors

Funding History

July 2015$10.9M
December 2016$8.0M
January 2019$30.0M

Management

Co-Founder & Chief Executive Officer

Peter Brodsky

Co-Founder

Krasimir Marinov

Co-Founder

Vladimir Tzankov

Chief Operating Officer

Charlie Newark-French

Chief Customer Officer

Timur Kalimov

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from HyperScience or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo